ÂÜÀòÂÒÂ×

Jorge Salazar García has an extensive background in the biotechnology industry. Jorge started as an R&D USP Technologist at Lonza in February 2019 and later joined Evox Therapeutics Ltd as an Associate Development Scientist in August 2020. Jorge then moved to INmune Bio Inc. in February 2021, where they held the roles of Senior Scientist and currently serves as the Lead GMP Development Scientist.

Jorge Salazar García completed a Bachelor's degree in Biology/Biological Sciences, General at Universitat d'Alacant from 2013 to 2017. Jorge then pursued a Master of Science in Cell/Cellular and Molecular Biology at the University of Sussex from 2017 to 2018. Additionally, in 2017, they participated in undergraduate research at Western Illinois University.